Acetylsalicylic acid disrupts SARS-CoV-2 spike protein glycosylation and selectively impairs binding to ACE2

Luca Perico(Mario Negri Institute for Pharmacological Research), Giuseppe Remuzzi(Mario Negri Institute for Pharmacological Research)
Frontiers in Immunology
January 7, 2026
Cited by 0


Related Papers